This morning Prof Adam Finn, a professor of paediatrics at the University of Bristol and a member of the Joint Committee on Vaccination and Immunisation (JCVI), said that figures up to 24 March showed 30 cases of CVST and seven deaths in the UK amongst more than 18 million people given the AstraZeneca jab. He said more up-to-date figures were due soon.
Most of these CVST cases are occurring in women under the age of 65 and Finn said this could lead to certain vaccines being used for certain age groups. Asked if younger people could be limited to certain vaccines, he told the Today programme:
"That’s certainly possible. We are seeing another vaccine coming in [Moderna], and further vaccines are approaching licensure, and I know that the UK has made contracts for quite a wide range of different vaccines. As time goes forward we will have much more flexibility about who can be offered what."